Results 11 to 20 of about 398,911 (393)

The Cerebellar Dopaminergic System [PDF]

open access: yesFrontiers in Systems Neuroscience, 2021
In the central nervous system (CNS), dopamine (DA) is involved in motor and cognitive functions. Although the cerebellum is not been considered an elective dopaminergic region, studies attributed to it a critical role in dopamine deficit-related ...
Paolo Flace   +11 more
doaj   +4 more sources

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism [PDF]

open access: yesJournal of Neuroscience, 2016
E. Aflaki   +17 more
semanticscholar   +3 more sources

Methyleugenol Has an Antidepressant Effect in a Neuroendocrine Model: In Silico and In Vivo Evidence

open access: yesPharmaceuticals, 2023
Major depressive disorder is a severe mood disorder characterized by different emotions and feelings. This study investigated the antidepressant activity of the phenylpropanoid methyleugenol (ME) in adult female mice exposed to a stress model induced by ...
Mayara Cecile Nascimento Oliveira   +13 more
doaj   +1 more source

Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction

open access: yesInternational Journal of Molecular Sciences, 2021
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia, responsible for the onset of several long-term complications. Recent evidence suggests that cognitive dysfunction represents an emerging complication of DM, but the ...
F. Pignalosa   +10 more
semanticscholar   +1 more source

Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?

open access: yesFuture Science OA, 2021
Neurodegenerative diseases, including Parkinson’s disease (PD), are increasing in the aging population. Crucially, neurodegeneration of dopaminergic neurons in PD is associated with chronic inflammation and glial activation.
Parisa Gazerani
doaj   +1 more source

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

open access: yesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
Purpose This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
S. Morbelli   +27 more
semanticscholar   +1 more source

Dopaminergic therapy in aphasia [PDF]

open access: yesAphasiology, 2013
The dopaminergic system is involved in a wide range of cognitive functions including motor control, reward, memory, attention, problem-solving and learning. This has stimulated interest in investigating the potential of dopaminergic drugs as cognitive enhancers in aphasic patients.To discuss the evidence for the use of dopaminergic agents in patients ...
Gill, SK, Leff, AP
openaire   +3 more sources

Synthetic route towards potential bivalent ligands possessing opioid and D2/D3 pharmacophores [PDF]

open access: yesJournal of the Serbian Chemical Society, 2019
A scalable, cost-efficient and simple synthetic pathway towards potential bivalent opioid/dopamine receptor ligands was developed and optimized. Three novel compounds that contain both opioid and dopamine pharmacophores linked by the four methylene group
Jevtić Ivana I.   +3 more
doaj   +1 more source

Levosulpiride-induced neurological adverse effects: A prospective study from a tertiary care center

open access: yesAnnals of Indian Academy of Neurology, 2020
Background: Levosulpiride (LS) is a prokinetic drug increasingly used for the gastric motility disorders. Despite its common use for the gastric motility disorder, the tendency to cause parkinsonism and acute dystonias are under-recognized as the major ...
Jacob Joe
doaj   +1 more source

Home - About - Disclaimer - Privacy